News of Note—PCI and ADC Bio add to manufacturing; recalls up

newspapers
(Pixabay)

> CDMO PCI Pharma Services began work Nov. 12 on a 30,000-square-foot expansion of its facility in Rockford, Illinois, that will add primary and secondary packaging and labeling of clinical supply and includes a temperature-controlled suite. Release

> ADC Biotechnology, which is working on a new and what it calls improved way to manufacture antibody-drug conjugates, has gotten £2.5 million from existing investors that will help it add a filling line to its manufacturing operation in Deeside, North Wales. Release

> Pharmaceutical recalls rose 19% in the third quarter, while recalled units fell 56% to just over 7 million, according to a survey by Stericycle Expert Solutions. Release

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.